Research Projects

The main objective of this first 2-year period as a post-doctoral research fellow at BWH/MGH Harvard Medical School is to get training in novel Magnetic Resonance Imaging (MRI) and Pittsburgh Compound B–Positron Emission Tomography (PIB-PET) techniques, their analysis methods, and applications to aging and age-related neurodegenerative diseases...

Neurodegenerative and neurodevelopmental diseases constitute a major health burden, and in spite of several decades of intensive research, the molecular mechanisms underlying these diseases are still poorly understood, and effective drug treatments are generally lacking. Alterations in protein synthesis have been implicated in several of these...

The JA will be contribute to public health programmes in Europe and develop Alzheimers disease (AD) and dementia prevention and care models in different European countries. The aim is to contribute to improvements in health by supporting and facilitating quality and efficiency of public health and healthcare policies and interventions. Synergy and...

Alzheimer’s disease (AD) is the leading cause of dementia in the Western world and to date no cure nor any preventive strategy are available for this neurodegenerative disorder. Bacterial 16S rRNA sequencing from fecal samples revealed a remarkable shift in the gut microbiota of conventionally-raised AD mice compared to healthy, wild-type mice...

Amyloid fibrils are likely causative or contributing agents in diseases such as Alzheimer’s disease, type 2 diabetes, Parkinson’s disease, and transmissible spongiform encephalopathies. AD represents a major health problem and heavy economic burden in industrialized countries. AD is characterized in pathology by the presence of several kinds of...

The 2015-2017 framework programme of Alzheimer Europe aims to achieve the following objectives:

1. Increasing knowledge about current national dementia policies and strategies, in order to promote best practices and reduce inequalities in dementia care in Europe (dementia-friendly communities, legal capacity and proxy decision making, care...

The 2015-2017 framework programme of Alzheimer Europe aims to achieve the following objectives: Increasing knowledge about current national dementia policies and strategies, in order to promote best practices and reduce inequalities in dementia care in Europe (dementia-friendly communities, legal capacity and proxy decision making, care standards...

Alzheimer Europe defines its mission as "changing perceptions, practice and policy in order to improve the access of people with dementia and their carers to treatment options and care services". To achieve its mission, Alzheimer Europe has defined the following six objectives in its strategic plan which covers the period of 2006-2010:Representing...

The key objectives of AE's 2016 activities are as follows:

• Increasing knowledge about current national dementia policies in order to promote best practices and reduce existing inequalities in dementia care in Europe;
• Promoting collaboration and exchange on ethical issues linked to dementia; Improving the involvement of people with dementia in...

The key objectives of Alzheimer Europe's 2017 operating grant are: the inventory and comparison of care standards for care services for people with dementia and their carers and the publiciation of results in the 2017 Dementia in Europe Yearbook, the analysis of ethical issues linked to societal obligations to people with dementia and the...

As part of its 2018 operating grant, Alzheimer Europe will aim to:

• Provide a voice to people with dementia by carrying out an inventory and analysis of existing working groups of people with dementia, their membership, working methods and findings and producing a report with the findings and identified good practices;
• Make dementia a European...

This application for a four-year framework partnership agreement is fully focused on dementia, one of the areas specifically identified as a priority area in the 2017 Call for proposals for operating grants. It builds on the work carried out by Alzheimer Europe in successive operating grants as part of its current framework partnership agreement...